Table 1. RUNX3 staining and clinicopathological characteristics of 300 renal cancer patients.
| Variables | RUNX3 staining | |||
|---|---|---|---|---|
| Low (%) | High (%) | Total | P * | |
| Age | ||||
| ≤56 years | 65 (45.8) | 77 (54.2) | 142 | 0.414 |
| >56 years | 64 (40.5) | 94 (59.5) | 158 | |
| Gender | ||||
| Male | 83 (41.1) | 119 (58.9) | 202 | 0.381 |
| Female | 46 (46.9) | 52 (53.1) | 98 | |
| Tumor size | ||||
| ≤7 cm | 99 (42.1) | 136 (57.9) | 235 | 0.574 |
| >7 cm | 30 (46.2) | 35 (53.8) | 65 | |
| Grade | ||||
| I | 3 (18.8) | 13 (71.2) | 16 | 0.765 |
| II | 56 (40.3) | 83 (59.7) | 139 | |
| III | 49 (39.8) | 74 (60.2) | 123 | |
| IV | 10 (45.4) | 12 (54.6) | 22 | |
| pT status | ||||
| pT1 | 78 (39.4) | 120 (60.6) | 198 | <0.001 |
| pT2 | 22 (46.8) | 25 (53.2) | 47 | |
| pT3 | 27 (60.0) | 18 (40.0) | 45 | |
| pT4 | 8 (80.0) | 2 (20.0) | 10 | |
| pN status | ||||
| N0 | 115 (42.0) | 159 (58.0) | 274 | 0.370 |
| N1-N3 | 10 (50.0) | 10 (50.0) | 20 | |
| pM status | ||||
| M0 | 117 (46.6) | 134 (53.4) | 251 | 0.728 |
| M1 | 3 (37.5) | 5 (62.5) | 8 | |
| TNM stage | ||||
| I | 73 (40.8) | 106 (59.2) | 179 | <0.001 |
| II | 19 (50.0) | 19 (50.0) | 38 | |
| III | 24 (63.2) | 14 (36.8) | 38 | |
| IV | 8 (72.7) | 3 (27.3) | 11 | |
*Two sided Fisher's exact tests.
Some cases were not available for the information.